Navigation Links
UBM Japan Pharma Events Grow Despite Air Travel Disruptions

AMSTERDAM, May 11 /PRNewswire/ -- Despite significant international travel restrictions due to the recent Icelandic volcanic cloud, leading events organiser UBM International Media and sister company UBM Japan Co. Ltd. today announced a record visitor attendance of 14,435 at its 2010 Japanese Pharma events cluster, which took place from 21-23 April at Tokyo's Big Sight Exhibition Center. Representing an increase of 3.8% over 2009 attendance levels, the success of the collocated events - CPhI Japan for intermediates and APIs; P-MEC Japan for pharma equipment and machinery; ICSE Japan for Contract Services and the BioPharma pavilion - reflects continuing growth in what is the second largest pharmaceutical market in the world after the United States.

On-site booking renewals for the 2011 events, scheduled for 18-20 April 2011, again at Tokyo Big Sight, are also at record levels, with many major exhibitors,  Abbott Japan Co. Ltd., Sinochem Jiangsu Corporation., Koa Shoji Co. Ltd, Dr. Reddy's Laboratories, Patheon and Jubilant Organosys having already confirmed space for next year. Last year exhibitor figures of 425 exhibitors from 28 countries were again surpassed, with the 2010 events attracting 450 exhibitors, including 282 non-Japanese organisations spanning 29 countries.

"Under the circumstances caused by the significant travel disruptions, we are delighted that our Japan portfolio continued to grow," commented Eliane van Doorn, UBM International Media's Group Director for Pharma events. "With the majority of European flights grounded during the week of the events and many of our valued international visitors and exhibitors unable to travel, we took steps to ensure they were kept up to date with everything going on in Tokyo via digital media. We constructed a dedicated webpage and updated this daily with seminar content, movies, pictures, a product directory and exhibitor downloads, while encouraging participation and networking for those unable to attend via a CPhI Japan Linked-In group."

In addition to the exhibition and networking elements, the 2010 events offered over 130 seminars and presentations, many of which were fully booked, and focused on dynamic changes in the Japanese pharmaceutical market, such as the revision of Japan's pharmaceutical law, growing competition from foreign companies, increased merger and acquisition activity and the rise in demand for generic drugs.  Highlights included the English language seminar - 'Revised Pharmaceutical Affairs Law Workshop' - which was organised by the Pharmaceuticals and Devices Agency, the Japan Generic Medicines Association and Japan Pharmaceutical Traders Association.

The BioPharma Pavilion, which made its debut during at CPhI Japan 2009, to showcase the most cutting-edge products and services to the Japanese market, was extended for 2010 and attracted strong interest, reflecting the increasing convergence of pharma and biotech business models in global healthcare, and the growing numbers of bio-pharma partnerships in drug innovation, production and market delivery.  

Formal supporters of the events included Japan's Ministry of Health, Labour and Welfare, the Ministry of Economy, Trade and Industry and 18 trade associations and industry organisations. The event's co-organiser was The Chemical Daily Co. Ltd., publisher of the highly respected Chemical Daily and Japan Chemical Week.

UBM International Media's CPhI family of events for the pharma ingredients and services sector includes Worldwide (Europe – October); China (June); South America (August) and India (December).

For further information on CPhI Japan see:, and

Notes for Editors:

  • UBM International Media operates market-leading global exhibition brands and their complementary media products. 
  • The CPhI pharmaceutical ingredients and related sector exhibitions currently number over 15 highly-regarded annual events. The portfolio also includes Informex (specialty chemicals), Food Ingredients, HBA (health & beauty industry) and Sea Trade (cruise industry).
  • Worldwide locations for its events include China, India, Japan, North America, Brazil, Africa and Europe.  More than 330,000 business professionals and marketers visit UBM exhibitions each year. The exhibitions portfolio is managed from Holland. UBM International Media has approximately 1,200 employees in the UK, US, Asia and Europe. See

SOURCE UBM International Media
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
3. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
4. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
5. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
6. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
7. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
8. Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
9. Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan
10. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
11. ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
Post Your Comments:
(Date:12/1/2015)... India , December 1, 2015 ... market research report "Immunotherapy Drugs Market by Type of Drug ... Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast ... is poised to reach USD 73,529.2 Million by 2020 from ... from 2015 to 2020. Browse 37 ...
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
(Date:12/1/2015)... 2015 During the recent 2015 Transcatheter ... Francisco, CA , Medinol Ltd. continued to ... During a satellite symposium, "The BioNIR eDES: The ... Restenosis", a renowned physician panel discussed the key ... Coronary Stent System and the Medinol eDES Coronary ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... IT Healthcare was recognized as a finalist in the category of Digital Solutions ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... 01, 2015 , ... PYA’s latest white paper, “ PYA ... main “pain point” for merging or aligning healthcare provider organizations—when mergers and other ... This quick-read guidance suggests that failing to recognize the power of an ...
(Date:12/1/2015)... ... 2015 , ... PartnerTech , a leader in high-tech ... 2008. Gary Bruce, President of PartnerTech North America, currently serves as Director for ... of time in Sweden since joining PartnerTech based in Malmo, Sweden. He has ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker of ... to date. , The order will be from the China Disabled Persons’ Federation, ... System is an effective solution for children and adults suffering from severe and ...
Breaking Medicine News(10 mins):